SEQENS
Budget
€10 — €0
EP Access
0
accredited persons
Staff
1
0.25 FTE
EU Grants
None
Mission & Goals
SEQENS is a world leader in the development and production of active pharmaceutical ingredients, intermediates and specialty ingredients, with 16 production sites, 9 R&D centers and 3,000 employees on 3 continents. As an integrated player across the entire value chain - from raw materials to active ingredients and from R&D to industrialization - SEQENS offers a broad portfolio of active pharmaceutical ingredients, pharmaceutical intermediates and specialty ingredients, develops and industrializes the most complex molecules, and leverages its ability to innovate, develop and implement the best available technologies.
EU Legislative Interests
EU Pharmaceutical Legislation EU Pharmaceutical Strategy Critical Medicines Alliance Electricity Market Design EU-ETS
Communication Activities
Member of the Critical Medicines Alliance (https://health.ec.europa.eu/health-emergency-preparedness-and-response-hera/overview/critical-medicines-alliance_en) Participation to JICF Member of the Critical Chemicals Alliance
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
CEFIC (https://cefic.org/) France Chimie (https://www.francechimie.fr/) EFCG (https://efcg.cefic.org/) SICOS (https://chimiefine-biochimie.fr/Le-SICOS-Biochimie) UNIDEN (https://www.uniden.fr/) MEDEF (https://www.medef.com/fr/)
Organisation Members
Cf. ci-dessus
Commissioner Meetings
No recorded meetings with EU commissioners.